This article is more than 5 years old. Information may no longer be current.

Enrollment complete in AcuFocus IC-8 IOL clinical trial

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

AcuFocus has completed enrollment in a pivotal investigational device exemption study of the IC-8, its small aperture IOL for patients with cataracts, according to a press release.

The IC-8, a clear monofocal lens with an embedded mini-ring or pinhole in the center, is designed to increase the natural range of vision by extending the focus of light rays that enter the eye, the release said.

The 12-month, prospective, multicenter, nonrandomized case control clinical trial will compare the IC-8 with traditional monofocal IOLs.

“Running a successful clinical trial depends on all participants — from the sponsor to the investigational sites — taking their role seriously and executing with high standards and focus,” Magda Michna, PhD, AcuFocus chief global clinical and regulatory affairs officer, said in the release. “I couldn’t be more pleased with the team and their efforts to meet the aggressive enrollment challenge we set forth.”